We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The Native Antigen Company Expands Into New Facilities

News   May 15, 2017 | Original story from The Native Antigen Company

 
The Native Antigen Company Expands Into New Facilities

Dr Nick Roesen, CSO, The Native Antigen Company

 
 
Advertisement
 

RELATED ARTICLES

Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer

News

Adaptate Biotherapeutics (Adaptate) today announced the appointment of Stewart Kay as Chief Business Officer (CBO).

READ MORE

Possible Role For Newly Discovered Immune Cell Population in MS

News

A team of investigators at Thomas Jefferson University have characterized a new population of T cells called ThGM cells that produce granulocyte macrophage-colony-stimulating factor (GM-CSF). The team has now uncovered key defining features of these cells and how they behave in an animal model of MS.

READ MORE

Investigational Drug Safely Slows Progression of Diabetic Kidney Disease in Clinical Trial

News

Patients with diabetic kidney disease could potentially be treated with an investigational new drug that may slow the progress of their illness without harmful adverse effects to their hearts, according to the results of a recent global clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE